1
|
Lemoine L, Buckinx F, Aidoud A, Leroy V, Fougère B, Aubertin-Leheudre M. Relationships between obesity markers and bone parameters in community-dwelling older adults. Aging Clin Exp Res 2024; 36:49. [PMID: 38421551 PMCID: PMC10904426 DOI: 10.1007/s40520-023-02673-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2023] [Accepted: 11/21/2023] [Indexed: 03/02/2024]
Abstract
BACKGROUND Osteoporosis is an age-related condition that can lead to fragility fractures and other serious consequences. The literature data on the impact of obesity on bone health are contradictory. The main reasons for this discrepancy could be the imperfect nature of the body mass index (BMI) as a marker of obesity, the metabolic status (inflammation and metabolically healthy obesity), and/or heterogeneity in bone variables and architecture or sex. AIMS To examine the relationship between bone variables and three validated obesity criteria. METHODS In this cross-sectional study, participants were classified as obese according to their BMI, waist circumference (WC), and fat mass (FM). Bone variables and architecture were assessed using dual-energy X-ray absorptiometry and peripheral quantitative computed tomography, respectively. RESULTS One hundred sixty-eight adults aged 55 or over (men: 68%) were included. 48 (28%) participants were obese according to the BMI, with 108 (64%) according to the FM, and 146 (87%) according to the WC. Bone variables were positively correlated with WC and BMI (Pearson's r = 0.2-0.42). In men only, the obesity measures were negatively correlated with cortical bone density (Pearson's r = - 0.32 to - 0.19) and positively correlated with cortical bone area (Pearson's r = 0.22-0.39). CONCLUSION Our findings indicate that independent of sex and obesity criteria, when significant, being obese seems to lead to higher bone parameters than being non-obese, except for cortical bone density. Thus, in the obese population, assessing cortical density might help the physician to identify bone alteration. Further researches are needed to confirm our findings.
Collapse
Affiliation(s)
- L Lemoine
- Division of Geriatric Medicine, Tours University Medical Centre, Tours, France.
- CHRU Tours - Service de Médecine Aigue Gériatrique, Hôpital Bretonneau, 2 Boulevard Tonnellé, 37044, Tours Cedex 9, France.
| | - F Buckinx
- Département des Sciences de l'activité Physique, Faculté des Sciences, Groupe de recherche en Activité Physique Adaptée (GRAPA), Université du Québec À Montréal, Montreal, QC, Canada
- Centre de recherche de l'Institut, Université de Gériatrie de Montréal, Montreal, QC, Canada
| | - A Aidoud
- Division of Geriatric Medicine, Tours University Medical Centre, Tours, France
- EA4245 T2i, Université de Tours, Tours, France
| | - V Leroy
- Division of Geriatric Medicine, Tours University Medical Centre, Tours, France
| | - B Fougère
- Division of Geriatric Medicine, Tours University Medical Centre, Tours, France
- EA 7505 Education, Ethics, Health, Tours University, Tours, France
| | - M Aubertin-Leheudre
- Département des Sciences de l'activité Physique, Faculté des Sciences, Groupe de recherche en Activité Physique Adaptée (GRAPA), Université du Québec À Montréal, Montreal, QC, Canada
- Centre de recherche de l'Institut, Université de Gériatrie de Montréal, Montreal, QC, Canada
| |
Collapse
|
2
|
Corbel A, Leroy V, Vesval Q, Rébillard A, Mathieu R. [Connected APA tools and prostate cancer: Literature review and experience feedback]. Prog Urol 2022; 32:880-887. [PMID: 36280376 DOI: 10.1016/j.purol.2022.09.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2022] [Accepted: 09/09/2022] [Indexed: 06/16/2023]
Abstract
Adapted physical activity (APA) appears to be essential for supportive care in oncology. It helps to reduce different side effects inherent to treatment and disease (e.g., fatigue, sarcopenia, balance problems) and could have an impact on patients' survival. However, it is not systematically implemented in daily practice and still too few patients reach the recommendations of physical activity. New tools, such as digital and connected ones, are now developed to overcome barriers to the implementation and daily practice of physical activity (e.g., distance between home and hospital). The aim of this article was to provide an overview of different connected tools that offer exercise training and monitoring programmes in prostate cancer.
Collapse
Affiliation(s)
- A Corbel
- Laboratoire « Mouvement, Sport, Santé » (EA 7470), université Rennes, campus de Ker Lann, Bruz, France.
| | - V Leroy
- Service d'urologie, centre hospitalier universitaire de Rennes, Rennes, France
| | - Q Vesval
- Service d'urologie, centre hospitalier universitaire de Rennes, Rennes, France
| | - A Rébillard
- Laboratoire « Mouvement, Sport, Santé » (EA 7470), université Rennes, campus de Ker Lann, Bruz, France
| | - R Mathieu
- Service d'urologie, centre hospitalier universitaire de Rennes, Rennes, France
| |
Collapse
|
3
|
Revegue MHDT, Jesson J, Dago-Akribi HA, Dahourou D, Ogbo P, Moh C, Amoussou-Bouah U, N’Gbeche MS, Eboua FT, Kouassi EM, Kouadio K, Cacou MC, Horo A, Msellati P, Sturm G, Leroy V. [Sexual and reproductive health of adolescents living with HIV in pediatric care programs in Abidjan : Structured provision of care and perceptions of health care workers in 2019]. Rev Epidemiol Sante Publique 2022; 70:163-176. [PMID: 35752510 PMCID: PMC9926011 DOI: 10.1016/j.respe.2022.04.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/07/2021] [Revised: 03/31/2022] [Accepted: 04/16/2022] [Indexed: 11/30/2022] Open
Abstract
INTRODUCTION The majority of adolescents living with HIV (ALHIV) reside in sub-Saharan Africa, with sexual and reproductive health (SRH) needs to be met. The health care facilities and professionals involved have a major role to assume in the quality of SRH services offered to these teenagers. OBJECTIVE To investigate the SRH services offered to ALHIV subjects in pediatric facilities in Abidjan, Ivory-Coast. METHODS In 2019 we conducted an exploratory cross-sectional study using qualitative and quantitative methods in three pediatric facilities caring for ALHIV subjects (CIRBA, CTAP and CePReF) and participating in the IeDEA (International epidemiologic databases to Evaluate AIDS project) in Abidjan, Ivory Coast. This study included: (1) an inventory of SRH services, using a questionnaire and direct observation, describing their adaptation to the teenagers' needs and their inclusion in provision of care; (2 an assessment by means of semi-structured interviews of 14 health professionals' perceptions of the SRH needs of the ALHIV subjects with whom they worked. Quantitative data were expressed in percentages and qualitative data from the interviews were analyzed through inductive thematic analysis. RESULTS The care provided in the three facilities was poorly adapted to the teenagers' needs. Few SRH services were effectively provided to the ALHIV subjects in the different centers. The services essentially consisted in condom distribution and organization of SRH-based focus groups. Exceptionally, hormonal contraception was offered to teenage girls. Barriers to the services were largely due to poorly equipped facilities, particularly in terms of SRH offer, health professionals' experience, and support provided for ALHIV subjects and their parents. The health professionals were desirous of SRH skill-building programs enabling them to deliver optimal, adequately contextualized SRH services to the teenagers. CONCLUSIONS In pediatric programs addressed to ALHIV subjects in three Abidjan facilities, the teenagers' SRH needs remain unmet. It is urgently necessary to strengthen the health facilities by means of improved equipment, enhanced awareness of teenagers' needs, and training programs enabling the health professionals to provide more adapted sexual and reproductive health services.
Collapse
Affiliation(s)
| | - J. Jesson
- Inserm, Université de Toulouse 3, CERPOP, Toulouse, France
| | - H. Aka Dago-Akribi
- Département de psychologie, Université de Cocody, Abidjan, Côte d’Ivoire
| | - D.L. Dahourou
- Département biomédical et de santé publique, Institut de recherche en sciences de la santé (IRSS/CNRST), Ouagadougou, Burkina Faso,Centre Muraz, Bobo-Dioulasso, Burkina Faso
| | - P. Ogbo
- Centre intégré de recherches biocliniques, Abidjan, Côte d’Ivoire
| | - C. Moh
- Département de psychologie, Université de Cocody, Abidjan, Côte d’Ivoire,Programme PACCI, Abidjan, Côte d’Ivoire
| | | | - M-S. N’Gbeche
- Centre de prise en charge, de recherche et de formation, CePReF, Aconda, Abidjan, Côte d’Ivoire
| | - F. Tanoh Eboua
- Department de pédiatrie, Centre hospitalier universitaire de Yopougon, Abidjan, Côte d’Ivoire
| | - E. Messou Kouassi
- Centre de prise en charge, de recherche et de formation, CePReF, Aconda, Abidjan, Côte d’Ivoire
| | - K. Kouadio
- Centre intégré de recherches biocliniques, Abidjan, Côte d’Ivoire
| | - M-C. Cacou
- Département de psychologie, Université de Cocody, Abidjan, Côte d’Ivoire
| | - A. Horo
- Service de gynécologie obstétrique, Centre hospitalier universitaire de Yopougon, Abidjan, Côte d’Ivoire
| | - P. Msellati
- Programme PACCI, Abidjan, Côte d’Ivoire,UMI TransVIHMI, Institut de recherche pour le développement, Montpellier, France
| | - G. Sturm
- Laboratoire cliniques psychopathologique et interculturelle EA4591, Université de Toulouse 2, Toulouse, France,Service universitaire de psychiatrie de l’enfant et de l’adolescent (SUPEA), CHU de Toulouse, Toulouse, France
| | - V. Leroy
- Inserm, Université de Toulouse 3, CERPOP, Toulouse, France
| | | |
Collapse
|
4
|
Hirschfield G, Berenguer M, Kremer AE, Jones D, Leroy V, Adekunle F, Carbone M. A209 EXPERT CONSENSUS CRITERIA AND PRACTICAL RECOMMENDATIONS FOR PBC CARE IN THE COVID-19 ERA AND BEYOND. J Can Assoc Gastroenterol 2022. [PMCID: PMC8859141 DOI: 10.1093/jcag/gwab049.208] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
Background Primary biliary cholangitis (PBC) is a chronic autoimmune cholestatic liver disease that can progress to liver fibrosis and cirrhosis, and requires timely diagnosis, optimal treatment, and risk stratification. Several guidelines for the management of PBC have been published, including the American Association for the Study of Liver Disease (AASLD) and European Association for the Study of the Liver (EASL) Clinical Practice Guidelines, which include goals for standards of PBC care. However, recent audits have identified deficiencies in real-world PBC care. In addition, the global coronavirus (COVID-19) pandemic has generally reduced access to care, diminished healthcare resources and accelerated the use of remote patient management. There is therefore a need for simple, actionable guidance that physicians can implement in order to maintain standards of care in PBC in the new environment. Aims A working group of ten PBC specialists from Europe and Canada were convened by Intercept Pharmaceuticals in January 2020 with the aim of defining key criteria for the care of patients with PBC. Methods Following the outbreak of the COVID-19 pandemic, based on these criteria, a smaller working group of six PBC specialists developed practical recommendations to assist physicians in maintaining standards of care and to guide remote management of patients. Results The working group defined five key criteria for care in PBC, encompassing PBC diagnosis, initiation of first line therapy with ursodeoxycholic acid (UDCA), risk stratification on UDCA, symptom management, and initiation of 2L therapy. The group developed 21 practical recommendations for the management of patients with PBC in the COVID-19 environment including modality, frequency and timing of investigations and monitoring. (Figure 1). Conclusions The delivery of PBC care during the COVID-19 pandemic carries significant challenges. These consensus criteria and practical recommendations provide guidance for the management of PBC during the pandemic era and beyond. ![]()
Funding Agencies NoneIntercept Pharmaceutical
Collapse
Affiliation(s)
- G Hirschfield
- Toronto Centre for Liver Disease, Toronto General Hospital, Toronto, ON, Canada
| | - M Berenguer
- Hepatology & Liver Transplant Unit, Le Fe University Hospital and Ciberehd, IIS La Fe, Universidad De Valencia, Valencia, Spain
| | - A E Kremer
- Friedrich Alexander University of Erlangen-Nurnberg, Erlangen, Germany
| | - D Jones
- Newcastle University, Newcastle upon Tyne, United Kingdom
| | - V Leroy
- Hepatology, Henri Mondor Hospital, Creteil, France
| | - F Adekunle
- Intercept Pharmaceuticals Inc, New York, NY
| | - M Carbone
- Division of Gastroenterology and Center for Autoimmune Liver Diseases, San Gerardo Hospital, Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy
| |
Collapse
|
5
|
Dagorno C, Sommacale D, Laurent A, Attias A, Mongardon N, Levesque E, Langeron O, Rhaiem R, Leroy V, Amaddeo G, Brustia R. Prehabilitation in hepato-pancreato-biliary surgery: A systematic review and meta-analysis. A necessary step forward evidence-based sample size calculation for future trials. J Visc Surg 2021; 159:362-372. [PMID: 34489200 DOI: 10.1016/j.jviscsurg.2021.07.003] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
Abstract
INTRODUCTION Prehabilitation is defined as preoperative conditioning of patients in order to improve post-operative outcomes. Some studies showed an increase in functional recovery following colorectal surgery, but its effect in hepato-pancreato-biliary (HPB) surgery is unclear. The aim of this study was to realize a systematic literature review and meta-analysis on the current available evidence on prehabilitation in HPB surgery. MATERIALS AND METHODS A systematic review and a metanalysis were carried out on prehabilitation (physical, nutritional and psychological interventions) in HPB surgery (2009-2019). Assessed outcomes were postoperative complications, length of stay (LOS), 30-day readmission, and mortality. MAIN RESULTS Four studies among the 191 screened were included in this systematic review (3 randomized controlled trials, 1 case-control propensity score study), involving 419 patients (prehabilitation group, n=139; control group, n=280). After pooling, no difference was observed on LOS ((-4.37 days [95% CI: -8.86; 0.13]) or postoperative complications (RR 0.83 [95%CI: 0.62; 1.10]), reported by all the included studies. Two trials reported on readmission rate, but given the high heterogeneity, a meta-analysis was not realized. No deaths were reported among the included studies. CONCLUSION No effect of prehabilitation programs in HPB surgery was observed on LOS or postoperative complications rate. Future trials with standardized outcomes of measure, and adequately powered samples calculations are thus required. PROSPERO REGISTRATION CRD42020165218.
Collapse
Affiliation(s)
- C Dagorno
- Université Paris Est Creteil, Faculté de Santé, 94010 Créteil, France; Department of Digestive and Hepato-pancreatic-biliary Surgery, DMU CARE, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Henri Mondor, 51, avenue du Maréchal de Lattre de Tassigny, 94010 Créteil, France
| | - D Sommacale
- Université Paris Est Creteil, Faculté de Santé, 94010 Créteil, France; Department of Digestive and Hepato-pancreatic-biliary Surgery, DMU CARE, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Henri Mondor, 51, avenue du Maréchal de Lattre de Tassigny, 94010 Créteil, France; Inserm U955, Team "Pathophysiology and Therapy of Chronic Viral Hepatitis and Related Cancers", France-Assistance Publique-Hôpitaux de Paris, Créteil, France
| | - A Laurent
- Université Paris Est Creteil, Faculté de Santé, 94010 Créteil, France; Department of Digestive and Hepato-pancreatic-biliary Surgery, DMU CARE, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Henri Mondor, 51, avenue du Maréchal de Lattre de Tassigny, 94010 Créteil, France
| | - A Attias
- Service d'anesthésie-réanimation chirurgicale, DMU CARE, DHU A-TVB, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Henri Mondor, 94010 Créteil, France
| | - N Mongardon
- Université Paris Est Creteil, Faculté de Santé, 94010 Créteil, France; Service d'anesthésie-réanimation chirurgicale, DMU CARE, DHU A-TVB, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Henri Mondor, 94010 Créteil, France; U955-IMRB, Equipe 03 "Pharmacologie et Technologies pour les Maladies Cardiovasculaires (PROTECT)", Inserm, University Paris Est Creteil (UPEC), Ecole Nationale Vétérinaire d'Alfort (EnVA), 94700 Maisons-Alfort, France
| | - E Levesque
- Université Paris Est Creteil, Faculté de Santé, 94010 Créteil, France; Service d'anesthésie-réanimation chirurgicale, DMU CARE, DHU A-TVB, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Henri Mondor, 94010 Créteil, France
| | - O Langeron
- Université Paris Est Creteil, Faculté de Santé, 94010 Créteil, France; Service d'anesthésie-réanimation chirurgicale, DMU CARE, DHU A-TVB, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Henri Mondor, 94010 Créteil, France
| | - R Rhaiem
- Department of General, Digestive and Endocrine Surgery, Robert-Debré University Hospital, University of Champagne-Ardennes, Reims, France
| | - V Leroy
- Université Paris Est Creteil, Faculté de Santé, 94010 Créteil, France; Inserm U955, Team "Pathophysiology and Therapy of Chronic Viral Hepatitis and Related Cancers", France-Assistance Publique-Hôpitaux de Paris, Créteil, France; Department of Hepatology, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Henri Mondor, 94010 Créteil, France
| | - G Amaddeo
- Université Paris Est Creteil, Faculté de Santé, 94010 Créteil, France; Inserm U955, Team "Pathophysiology and Therapy of Chronic Viral Hepatitis and Related Cancers", France-Assistance Publique-Hôpitaux de Paris, Créteil, France; Department of Hepatology, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Henri Mondor, 94010 Créteil, France
| | - R Brustia
- Department of Digestive and Hepato-pancreatic-biliary Surgery, DMU CARE, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Henri Mondor, 51, avenue du Maréchal de Lattre de Tassigny, 94010 Créteil, France.
| |
Collapse
|
6
|
Kaulanjan K, Thenault R, Leroy V, Khene Z, Mathieu R. Hormonothérapie dans le cancer de la prostate : quel rôle pour l’IDE en 2020 ? Prog Urol 2020; 30:958-963. [DOI: 10.1016/j.purol.2020.09.022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2020] [Accepted: 09/24/2020] [Indexed: 10/23/2022]
|
7
|
Roux M, De Ledinghen V, Leroy V, Riou J, Foucher J, Irles M, Calès P, Boursier J. Diagnostic non invasif de cirrhose dans la « non-alcoholic fatty liver disease » (NAFLD). Rev Epidemiol Sante Publique 2020. [DOI: 10.1016/j.respe.2020.03.061] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
8
|
Newsome P, Schattenberg J, Serfaty L, Aghemo A, Augustin S, Tsochatzis E, Canbay A, Ledinghen V, Bugianesi E, Romero-Gomez M, Ryder S, Bantel H, Boursier J, Petta S, Crespo J, Castera L, Leroy V, Le Pen C, Fricke F, Elliott R, Atella V, Mestre-Ferrandiz J, Floros L, Torbica A, Morgan A, Hartmanis S, Trylesinki A, Cure S, Stirzaker E, Vasudevan S, Pezzulo L, Ratziu V. The economic cost and health burden of non-alcoholic steatohepatitis in the EU5 countries. Dig Liver Dis 2020. [DOI: 10.1016/j.dld.2019.12.121] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/18/2023]
|
9
|
Dahourou DL, Masson D, Aka-Dago-Akribi H, Gauthier-Lafaye C, Cacou C, Raynaud JP, Moh C, Bouah B, Sturm G, Oga M, Msellati P, Leroy V. [HIV Disclosure to the Child/Adolescent in Central and West Francophone Africa]. Bull Soc Pathol Exot 2019; 112:14-21. [PMID: 31225728 DOI: 10.3166/bspe-2019-0063] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 10/26/2018] [Accepted: 02/22/2019] [Indexed: 11/20/2022]
Abstract
We report the attitudes and practices of health care workers involved in the disclosure process to adolescents living with HIV (ALHIV) in a network including West and Central African French-speaking countries, and the experiences of young living with HIV (YLHIV). During a three-day workshop in Abidjan, Côte d'Ivoire, caregivers (doctors, psychologists, social workers) from 19 pediatric HIV treatment sites shared their practices and difficulties, and four YPLHIV their own disclosure experience. Thirty five participants from eight West/Central African countries (Benin, Burkina Faso, Ivory Coast, Cameroon, Mali, Democratic Republic of Congo, Senegal, Togo) contributed: 14 doctors, eight psychologists, six counselors, three social workers. The experience of the centers was variable, but the age at disclosure was late: 34% of 1296 adolescents between 10 and 12 years of age knew their status. The median age at disclosure was 13 years (range: 11-15 years). The practice of the disclosure was often complex, because of multiple factors (fear of the parents of the breaking of the secrecy, lack of communication between professionals). The individual disclosure was the main practice. Four centers practiced HIV disclosure in group sessions to facilitate mirror support, and one used peer-to-peer support. YPLHIV have advocated for an earlier disclosure, from 10 years. In West and Central Africa, the process of HIV disclosure remains complex for parents and caregivers, and occurs too late. The development of a good practice guideline for HIV disclosing adapted to socio-cultural contexts should help to improve this process.
Collapse
Affiliation(s)
| | - D Masson
- Programme Grandir, Paris, France
| | - H Aka-Dago-Akribi
- Département de psychologie, Université Félix Houphouët-Boigny, PACCI, Abidjan, Côte d'Ivoire
| | - C Gauthier-Lafaye
- Service universitaire de psychiatrie de l'enfant et de l'adolescent (SUPEA), CHU de Toulouse, Toulouse, France
| | - C Cacou
- Département de psychologie, Université Félix Houphouët-Boigny, PACCI, Abidjan, Côte d'Ivoire
| | - J-P Raynaud
- Service universitaire de psychiatrie de l'enfant et de l'adolescent (SUPEA), CHU de Toulouse, Toulouse, France.,INSERM U1027, Université de Toulouse 3, Toulouse, France
| | - C Moh
- Département de psychologie, Université Félix Houphouët-Boigny, PACCI, Abidjan, Côte d'Ivoire
| | - B Bouah
- Département de psychologie, Université Félix Houphouët-Boigny, PACCI, Abidjan, Côte d'Ivoire
| | - G Sturm
- Laboratoire cliniques psychopathologique et interculturelle, Université Jean Jaurès Toulouse 2, Toulouse
| | | | - P Msellati
- IRD, UMI 233, U1175 INSERM, Université de Montpellier, PACCI, Abidjan
| | - V Leroy
- INSERM U1027, Université de Toulouse 3, Toulouse, France
| | | |
Collapse
|
10
|
Veni T, Leroy V, Pradère B, Rébillard A, Mathieu R. [Patients with prostate cancer treated by androgen deprivation therapy: Impact of adapted physical activity]. Prog Urol 2019; 29:912-916. [PMID: 31635895 DOI: 10.1016/j.purol.2019.09.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/03/2019] [Revised: 09/26/2019] [Accepted: 09/27/2019] [Indexed: 11/15/2022]
Abstract
OBJECTIVES The purpose of this article is to present adapted physical activity (APA) and its potential impact on the androgen deprivation therapy (ADT) adverse effects, the limits and measures to promote its use among prostate cancer (PCa) patients treated with ADT. MATERIAL AND METHODS A non-systematic review of the literature was performed with pubmed referenced articles, using the keywords "prostate cancer", "androgen deprivation" and "physical activity", and the main publications and recommendations of national and international health agencies, published between January 2010 and June 2019. RESULTS APA represents an effective action to reduce adverse effects of ADT. Its integration into health care of PCa patients treated with ADT remains limited. CONCLUSION To promote a APA development in this population, a multidisciplinary collaboration between healthcare and APA professionals is essential. This collaboration should enable implementation of standard and innovative APA programs and therapeutic education tools for patients, as well as development of information and promotion for healthcare professionals.
Collapse
Affiliation(s)
- T Veni
- Laboratoire « Mouvement, Sport, Santé » (EA 7470), université Rennes, Campus de Ker-Lann, 35170 Bruz, France.
| | - V Leroy
- Service urologie, centre hospitalier universitaire de Rennes, 35033 Rennes, France
| | - B Pradère
- Service urologie, CHRU Bretonneau, 37044 Tours, France; PRES Centre Val de Loir, université François-Rabelais-de-Tours, 37041 Tours, France
| | - A Rébillard
- Laboratoire « Mouvement, Sport, Santé » (EA 7470), université Rennes, Campus de Ker-Lann, 35170 Bruz, France
| | - R Mathieu
- Service urologie, centre hospitalier universitaire de Rennes, 35033 Rennes, France
| |
Collapse
|
11
|
Schomaker M, Luque-Fernandez MA, Leroy V, Davies MA. Using longitudinal targeted maximum likelihood estimation in complex settings with dynamic interventions. Stat Med 2019; 38:4888-4911. [PMID: 31436859 DOI: 10.1002/sim.8340] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/14/2018] [Revised: 07/10/2019] [Accepted: 07/19/2019] [Indexed: 11/12/2022]
Abstract
Longitudinal targeted maximum likelihood estimation (LTMLE) has very rarely been used to estimate dynamic treatment effects in the context of time-dependent confounding affected by prior treatment when faced with long follow-up times, multiple time-varying confounders, and complex associational relationships simultaneously. Reasons for this include the potential computational burden, technical challenges, restricted modeling options for long follow-up times, and limited practical guidance in the literature. However, LTMLE has desirable asymptotic properties, ie, it is doubly robust, and can yield valid inference when used in conjunction with machine learning. It also has the advantage of easy-to-calculate analytic standard errors in contrast to the g-formula, which requires bootstrapping. We use a topical and sophisticated question from HIV treatment research to show that LTMLE can be used successfully in complex realistic settings, and we compare results to competing estimators. Our example illustrates the following practical challenges common to many epidemiological studies: (1) long follow-up time (30 months); (2) gradually declining sample size; (3) limited support for some intervention rules of interest; (4) a high-dimensional set of potential adjustment variables, increasing both the need and the challenge of integrating appropriate machine learning methods; and (5) consideration of collider bias. Our analyses, as well as simulations, shed new light on the application of LTMLE in complex and realistic settings: We show that (1) LTMLE can yield stable and good estimates, even when confronted with small samples and limited modeling options; (2) machine learning utilized with a small set of simple learners (if more complex ones cannot be fitted) can outperform a single, complex model, which is tailored to incorporate prior clinical knowledge; and (3) performance can vary considerably depending on interventions and their support in the data, and therefore critical quality checks should accompany every LTMLE analysis. We provide guidance for the practical application of LTMLE.
Collapse
Affiliation(s)
- M Schomaker
- Centre for Infectious Disease Epidemiology & Research, University of Cape Town, Cape Town, South Africa.,Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics and Technology, Hall in Tirol, Austria
| | - M A Luque-Fernandez
- Biomedical Research Institute of Granada - Noncommunicable and Cancer Epidemiology Group, Andalusian School of Public Health, University of Granada, Granada, Spain.,Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK.,Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts
| | | | - M A Davies
- Centre for Infectious Disease Epidemiology & Research, University of Cape Town, Cape Town, South Africa
| |
Collapse
|
12
|
Viglino D, Plazanet A, Bailly S, Benmerad M, Jullian-Desayes I, Tamisier R, Leroy V, Zarski J, Maignan M, Joyeux-Faure M, Pepin J. Impact de la stéatopathie métabolique sur la survenue d’événements cardiovasculaires et la mortalité des patients BPCO. Rev Mal Respir 2019. [DOI: 10.1016/j.rmr.2018.10.128] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
13
|
Veni T, Khene Z, Leroy V, Bensalah K, Verhoest G, Vincendeau S, Rebillard A, Mathieu R. Mise en place d’un programme d’activité physique adaptée dans un service d’urologie pour les patients atteints d’un cancer de la prostate traités par hormonothérapie : étude de faisabilité. Prog Urol 2018. [DOI: 10.1016/j.purol.2018.07.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
14
|
Anty R, Favre G, Coilly A, Rossignol E, Houssel-Debry P, Duvoux C, De Ledinghen V, Di Martino V, Leroy V, Radenne S, Kamar N, Canva V, D'Alteroche L, Durand F, Dumortier J, Lebray P, Besch C, Tran A, Canivet CM, Botta-Fridlund D, Montialoux H, Moreno C, Conti F, Silvain C, Perré P, Habersetzer F, Abergel A, Debette-Gratien M, Dharancy S, Esnault VLM, Fougerou-Leurent C, Cagnot C, Diallo A, Veislinger A, Danjou H, Samuel D, Pageaux GP, Duclos-Vallée JC. Safety of sofosbuvir-based regimens after liver transplantation: longitudinal assessment of renal function in the prospective ANRS CO23 CUPILT study. Aliment Pharmacol Ther 2018; 47:1682-1689. [PMID: 29665081 DOI: 10.1111/apt.14639] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/07/2017] [Revised: 01/09/2018] [Accepted: 03/07/2018] [Indexed: 01/01/2023]
Abstract
BACKGROUND In liver transplant recipients with hepatitis C virus recurrence, there is concern about renal safety of sofosbuvir-based regimens. Changes in serum creatinine or in the estimated glomerular filtration rate (eGFR) under treatment are used to look for possible renal toxicity. However, serum creatinine and eGFR are highly variable. AIM To analyse renal function trajectory with numerous assays of serum creatinine over a long period of time. METHODS In a multicentre cohort of 139 patients, the eGFR was obtained from serum creatinine using the Chronic Kidney Disease-Epidemiology Collaboration (CKD-EPI) equation. Slopes of eGFR were defined as a change in eGFR during a period divided by time. Pre-treatment, on-treatment and post-treatment periods were 9 months, 3-9 months and 4.5 months. Interactions between eGFR slopes and the pre-treatment eGFR, use of ribavirin or mycophenolate mofetil, and stage of fibrosis were addressed. On-treatment eGFR slopes were separated in tertiles. Pre- and post-treatment eGFR slopes were compared globally and according to tertiles. RESULTS The post-treatment eGFR slope was significantly better than pre-treatment eGFR slope (+0.18 (IQR -0.76 to +1.32) vs -0.11 (IQR -1.01 to +0.73) mL/min/1.73 m2 /month, P = 0.03) independently of the pre-treatment eGFR (P = 0.99), ribavirin administration (P = 0.26), mycophenolate mofetil administration (P = 0.51) and stage of fibrosis (F3 and F4 vs lower stages, P = 0.18; F4 vs lower stages, P = 0.08; F4 Child-Pugh B and C vs lower stages, P = 0.38). Tertiles of on-treatment eGFR slopes were -1.71 (IQR -2.54 to -1.48), -0.78 (IQR -1.03 to -0.36) and +0.75 (IQR +0.28 to +1.47) mL/min/1.73 m2 /month. Pre- and post-treatment eGFR slopes were not significantly different according to tertiles (respectively, P = 0.34, 0.08, 0.73). CONCLUSION The eGFR varies during treatment and gives a confusing picture of the renal safety of sofosbuvir-based regimens. In contrast, longitudinal assessment of the eGFR shows a rising trajectory over longer time, meaning that these therapies are safe for the kidneys in our cohort of liver transplant recipients.
Collapse
|
15
|
|
16
|
Rosenthal E, Fougerou-Leurent C, Renault A, Carrieri MP, Marcellin F, Garraffo R, Teicher E, Aumaitre H, Lacombe K, Bailly F, Billaud E, Chevaliez S, Dominguez S, Valantin MA, Reynes J, Naqvi A, Cotte L, Metivier S, Leroy V, Dupon M, Allegre T, De Truchis P, Jeantils V, Chas J, Salmon-Ceron D, Morlat P, Neau D, Perré P, Piroth L, Pol S, Bourlière M, Pageaux GP, Alric L, Zucman D, Girard PM, Poizot-Martin I, Yazdanpanah Y, Raffi F, Pabic EL, Tual C, Pailhé A, Amri I, Bellissant E, Molina JM. Efficacy, safety and patient-reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor-experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study). HIV Med 2017; 19:227-237. [PMID: 29214737 DOI: 10.1111/hiv.12571] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/19/2017] [Indexed: 12/26/2022]
Abstract
OBJECTIVES Studies evaluating the efficacy and safety of the fixed-dose combination ledipasvir (LDV)/sofosbuvir (SOF) in patients coinfected with HIV-1 and hepatitis C virus (HCV) have mainly included treatment-naïve patients without cirrhosis. We aimed to evaluate the efficacy and safety of this combination in treatment-experienced patients with and without cirrhosis. METHODS We conducted a multicentre, open-label, double-arm, nonrandomized study in patients coinfected with HIV-1 and HCV genotype 1 with and without cirrhosis, who had good viral suppression on their antiretroviral regimens. All patients were pretreated with a first-generation NS3/4A protease inhibitor (PI) plus pegylated interferon/ribavirin. Patients received a fixed-dose combination of LDV/SOF for 12 weeks, or for 24 weeks if cirrhosis was present. The primary endpoint was a sustained virological response (SVR) 12 weeks after the end of therapy. Secondary endpoints included safety, pharmacokinetics and patient-reported outcomes. RESULTS Of the 68 patients enrolled, 39.7% had cirrhosis. Sixty-five patients [95.6%; 95% confidence interval (CI): 87.6-99.1%; P < 0.0001] achieved an SVR, with similar rates of SVR in those with and without cirrhosis. Tolerance was satisfactory, with mainly grade 1 or 2 adverse events. Among patient-reported outcomes, only fatigue significantly decreased at the end of treatment compared with baseline [odds ratio (OR): 0.36; 95% CI: 0.14-0.96; P = 0.04]. Mean tenofovir area under the plasma concentration-time curve (AUC) at week 4 was high, with mean ± SD AUC variation between baseline and week 4 higher in cirrhotic than in noncirrhotic patients (3261.57 ± 1920.47 ng/mL vs. 1576.15 ± 911.97 ng/mL, respectively; P = 0.03). Mild proteinuria (54.4%), hypophosphataemia (50.0%), blood bicarbonate decrease (29.4%) and hypokalaemia (13.2%) were reported. The serum creatinine level was not modified. CONCLUSIONS LDV/SOF provided a high SVR rate in PI-experienced subjects coinfected with HCV genotype 1 and HIV-1, including patients with cirrhosis.
Collapse
Affiliation(s)
- E Rosenthal
- Internal Medicine Department, CHU de Nice, Hôpital Archet 1, Nice, France
| | - C Fougerou-Leurent
- Pharmacology Department, CHU Rennes, Rennes, France.,Inserm, CIC1414, Rennes, France
| | - A Renault
- Inserm, CIC1414, Rennes, France.,Pharmacology Laboratory, Faculté de Médecine, Univ Rennes 1, Rennes, France
| | - M P Carrieri
- Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, Inserm, IRD, Aix Marseille Univ, Marseille, France.,Observatoire Régional de la Santé Provence-Alpes-Côte d'Azur, Marseille, France
| | - F Marcellin
- Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, Inserm, IRD, Aix Marseille Univ, Marseille, France.,Observatoire Régional de la Santé Provence-Alpes-Côte d'Azur, Marseille, France
| | - R Garraffo
- Clinical Pharmacology and Toxicology Department, CHU de Nice, Nice, France
| | - E Teicher
- Infectious Diseases Department, APHP, Hôpital Bicêtre, Le Kremlin Bicêtre, France
| | - H Aumaitre
- Infectious and Tropical Diseases Department, Hôpital de Perpignan, Perpignan, France
| | - K Lacombe
- Infectious Diseases Department, APHP, Hôpital Saint Antoine, Paris, France
| | - F Bailly
- Hepatology Department, HCL, Hôpital de la Croix-Rousse, Lyon, France
| | - E Billaud
- Infectious Diseases Department, CHU Nantes, Nantes, France
| | - S Chevaliez
- Virology Department, APHP, Hôpital Henri Mondor, Créteil, France
| | - S Dominguez
- Clinical Immunology Department, APHP, Hôpital Henri Mondor, Créteil, France
| | - M A Valantin
- Infectious Diseases Department, APHP, Hôpital La Pitié Salpêtrière, Paris, France
| | - J Reynes
- Infectious Diseases Department, CHU Montpellier, Montpellier, France
| | - A Naqvi
- Infectious Diseases Department, CHU de Nice, Hôpital Archet 1, Nice, France
| | - L Cotte
- Infectious Diseases Department, HCL, Hôpital de la Croix-Rousse, Lyon, France
| | - S Metivier
- Hepatogastroenterology Department, CHU Toulouse, Toulouse, France
| | - V Leroy
- Hepatogastroenterology Department, CHU Grenoble, Grenoble, France
| | - M Dupon
- Infectious Diseases Department, CHU Bordeaux, Bordeaux, France
| | - T Allegre
- Hemato Oncology Department, CH du Pays d'Aix, Aix-en-Provence, France
| | - P De Truchis
- Infectious Diseases Department, APHP, Hôpital R Poincaré, Garches, France
| | - V Jeantils
- Infectious Diseases Department, APHP, Hôpital J Verdier, Bondy, France
| | - J Chas
- Infectious and Tropical Diseases Department, APHP, Hôpital Tenon, Paris, France
| | - D Salmon-Ceron
- Infectious Diseases Department, APHP, Hôpital Cochin, Paris, France
| | - P Morlat
- Internal Medicine and Infectious Diseases Department, CHU Bordeaux, Bordeaux, France
| | - D Neau
- Infectious and Tropical Diseases Department, CHU Bordeaux, Bordeaux, France
| | - P Perré
- Internal Medicine Department, CHD Vendée, La Roche sur Yon, France
| | - L Piroth
- Infectious Diseases Department, CHU Dijon, Dijon, France
| | - S Pol
- Hepato-Gastroenterology Department, APHP, Hôpital Cochin, Paris, France
| | - M Bourlière
- Hepatogastroenterology Department, Hôpital Saint Joseph, Marseille, France
| | - G P Pageaux
- Hepatogastroenterology Department, CHU Montpellier, Montpellier, France
| | - L Alric
- Internal Medicine Department, CHU Toulouse, Toulouse, France
| | - D Zucman
- Internal Medicine Department, Hôpital Foch, Suresne, France
| | - P M Girard
- Infectious Diseases Department, APHP, Hôpital Saint Antoine, Paris, France
| | - I Poizot-Martin
- Immuno and Clinical Hematology department, APHM Sainte-Marguerite, Aix Marseille Univ, Marseille, France.,Inserm U912 (SESSTIM), Marseille, France
| | - Y Yazdanpanah
- Infectious and Tropical Diseases Department, APHP, Hôpital Bichat, Paris, France
| | - F Raffi
- Infectious Diseases Department, CHU Nantes, Nantes, France
| | - E Le Pabic
- Pharmacology Department, CHU Rennes, Rennes, France.,Inserm, CIC1414, Rennes, France
| | - C Tual
- Pharmacology Department, CHU Rennes, Rennes, France.,Inserm, CIC1414, Rennes, France
| | - A Pailhé
- Unité de Recherche Clinique et Fondamentale sur les Hépatites Virales, ANRS (France Recherche Nord & Sud Sida-hiv Hépatites), Paris, France
| | - I Amri
- Unité de Recherche Clinique et Fondamentale sur les Hépatites Virales, ANRS (France Recherche Nord & Sud Sida-hiv Hépatites), Paris, France
| | - E Bellissant
- Pharmacology Department, CHU Rennes, Rennes, France.,Inserm, CIC1414, Rennes, France.,Pharmacology Laboratory, Faculté de Médecine, Univ Rennes 1, Rennes, France
| | - J M Molina
- Hepatogastroenterology Department, APHP, Hôpital Saint Louis, Paris, France
| | | |
Collapse
|
17
|
Elias F, Kosgodagan Acharige S, Rose L, Gay C, Leroy V, Derec C. Vibration of soap films and Plateau borders, as elementary blocks of a vibrating liquid foam. Colloids Surf A Physicochem Eng Asp 2017. [DOI: 10.1016/j.colsurfa.2017.02.091] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
18
|
Leroy V, Blasco H, Journaud M, Bigot A, Maillot F, Magnant J. Acidose pyroglutamique chronique sur consommation chronique de paracétamol. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.10.242] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
19
|
Leroy V, Henrot P, Barnetche T, Cario-André M, Taïeb A, Truchetet ME, Seneschal J. Association entre troubles pigmentaires et atteintes systémiques de la sclérodermie : étude d’une série de 239 patients. Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.500] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
20
|
Lombard O, Barrière C, Leroy V. Ultrasonic subwavelength phase conjugated mirror with a layer of bubbles. Ultrasonics 2017; 78:110-114. [PMID: 28334635 DOI: 10.1016/j.ultras.2017.03.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/09/2017] [Revised: 03/09/2017] [Accepted: 03/12/2017] [Indexed: 06/06/2023]
Abstract
A single layer of gas bubbles in a yield-stress fluid is experimentally shown to behave as a phase-conjugated (PC) mirror with a thickness 250 times smaller than the wavelength (0.14mm-diameter bubbles for phase-conjugation at 40kHz). A high amplitude pump wave at frequency 80kHz interacts with a lower amplitude probe wave centered at 40kHz. A PC-reflection coefficient of 0.15 is obtained for a 50kPa pump. A perturbative second-order theory is shown to quantitatively describe the experimental observations.
Collapse
Affiliation(s)
- O Lombard
- Laboratoire Matière et Systèmes Complexes, Universitè Paris-Diderot, CNRS (UMR 7057), Paris, France.
| | - C Barrière
- Institut Langevin, ESPCI ParisTech, CNRS (UMR 7587), PSL Research University, Paris, France
| | - V Leroy
- Laboratoire Matière et Systèmes Complexes, Universitè Paris-Diderot, CNRS (UMR 7057), Paris, France
| |
Collapse
|
21
|
Affiliation(s)
- J.-J. Huet
- Centre d'Etude de I'Energie Nucléaire CEN/SCK, 1144, Avenue E. Plasky, B-1040, Bruxelles, Belgique
| | - V. Leroy
- Centre d'Etude de I'Energie Nucléaire CEN/SCK, 1144, Avenue E. Plasky, B-1040, Bruxelles, Belgique
| |
Collapse
|
22
|
Ilberg D, Saphier D, Yiftah S, Duchatelle L, Nucheze LD, Robin MG, Brodrick JR, Lowe PA, Burchill WE, McCormick NJ, Schenter RE, McCormick NJ, Wantland JL, Fontana MH, MacPherson RE, Gnadt PA, Parsly LF, Wantland JL, Ward AL, Huet JJ, Leroy V, Krankota JL, Armijo JS, Leibowitz L, Williams C, Chasanov MG, Moore RE, Barton CJ, Tzou CK, Yang CM, Prasad KN, Jester WA, Remick FJ. Authors. NUCL TECHNOL 2017. [DOI: 10.13182/nt74-a31467] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
23
|
|
24
|
Messien P, Herman J, Leroy V, Harlet P, Huge J, Detry J, Cantinieaux P. Laminage ferritique de bandes à chaud minces en acier doux. ACTA ACUST UNITED AC 2017. [DOI: 10.1051/metal/199188050433] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
|
25
|
Carré M, Thiebaut-Bertrand A, Larrat S, Leroy V, Pouzol P, Sturm N, Lhomme S, Cahn JY, Garban F, Morand P. Fatal autochthonous fulminant hepatitis E early after allogeneic stem cell transplantation. Bone Marrow Transplant 2017; 52:643-645. [PMID: 28067868 DOI: 10.1038/bmt.2016.337] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/24/2023]
Affiliation(s)
- M Carré
- Clinique Universitaire d'Hématologie, CHU de Grenoble Alpes, La Tronche, France
| | - A Thiebaut-Bertrand
- Clinique Universitaire d'Hématologie, CHU de Grenoble Alpes, La Tronche, France
| | - S Larrat
- Laboratoire de Virologie, Institut de Biologie Structurale (UMR 5075), Univ. Grenoble Alpes, CEA, CNRS, Grenoble, France
| | - V Leroy
- Clinique Universitaire d'Hépato-gastro-entérologie, CHU de Grenoble Alpes, La Tronche, France
| | - P Pouzol
- Unité d'hémovigilance et sécurité transfusionnelle, pôle de santé publique, CHU de Grenoble Alpes, La Tronche, France
| | - N Sturm
- Département d'Anatomie et de Cytologie Pathologiques, pôle de Biologie CHU de Grenoble Alpes, La Tronche, France
| | - S Lhomme
- INSERM UMR 1043/CNRS UMR 5282, Université Toulouse III, National Reference Center HEV, CHU Toulouse, Toulouse, France
| | - J-Y Cahn
- Clinique Universitaire d'Hématologie, CHU de Grenoble Alpes, La Tronche, France.,UMR CNRS 5525 équipe THEREX Université de Grenoble Alpes, Grenoble, France
| | - F Garban
- Clinique Universitaire d'Hématologie, CHU de Grenoble Alpes, La Tronche, France.,UMR CNRS 5525 équipe THEREX Université de Grenoble Alpes, Grenoble, France.,Etablissement Français du Sang, site de Grenoble, La Tronche, France
| | - P Morand
- Laboratoire de Virologie, Institut de Biologie Structurale (UMR 5075), Univ. Grenoble Alpes, CEA, CNRS, Grenoble, France
| |
Collapse
|
26
|
Viglino D, Jullian-Desayes I, Minoves M, Aron-Wisnewsky J, Leroy V, Zarski J, Tamisier R, Joyeux-Faure M, Pepin J. La stéatose hépatique non alcoolique (NAFLD) dans la bronchopneumopathie chronique obstructive (BPCO). Rev Mal Respir 2017. [DOI: 10.1016/j.rmr.2016.10.128] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
27
|
Leroy V, Templier C, Faivre J, Scherpereel A, Fournier C, Mortier L, Wémeau-Stervinou L. Pneumopathies interstitielles diffuses secondaires au pembrolizumab. Rev Mal Respir 2017. [DOI: 10.1016/j.rmr.2016.10.349] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
28
|
Leroy V, Kouakou K, Malateste K, Dicko F, Desmonde S, Folquet-Amorissani M. Cascade d’accès au traitement antirétroviral et rétention à 12 mois des enfants infectés par le VIH dans la collaboration IeDEA d’Afrique de l’Ouest (pWADA). Rev Epidemiol Sante Publique 2016. [DOI: 10.1016/j.respe.2016.06.063] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
29
|
Leroy V, Lazaro E, Darrigade A, Taïeb A, Milpied B, Seneschal J. Successful rapid subcutaneous desensitization to anakinra in a case of delayed‐type hypersensitivity reaction. Br J Dermatol 2016; 174:1417-8. [DOI: 10.1111/bjd.14454] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- V. Leroy
- Department of Dermatology and Paediatric Dermatology National Reference Center for Rare Skin Disorders Hôpital Saint‐André University of Bordeaux 1 Rue Jean Burguet 33075 Bordeaux CEDEX France
| | - E. Lazaro
- Department of Internal Medicine Hôpital du Haut‐Lévêque University of Bordeaux Pessac France
| | - A.‐S. Darrigade
- Department of Dermatology and Paediatric Dermatology National Reference Center for Rare Skin Disorders Hôpital Saint‐André University of Bordeaux 1 Rue Jean Burguet 33075 Bordeaux CEDEX France
| | - A. Taïeb
- Department of Dermatology and Paediatric Dermatology National Reference Center for Rare Skin Disorders Hôpital Saint‐André University of Bordeaux 1 Rue Jean Burguet 33075 Bordeaux CEDEX France
- INSERM U1035 University of Bordeaux Bordeaux France
| | - B. Milpied
- Department of Dermatology and Paediatric Dermatology National Reference Center for Rare Skin Disorders Hôpital Saint‐André University of Bordeaux 1 Rue Jean Burguet 33075 Bordeaux CEDEX France
| | - J. Seneschal
- Department of Dermatology and Paediatric Dermatology National Reference Center for Rare Skin Disorders Hôpital Saint‐André University of Bordeaux 1 Rue Jean Burguet 33075 Bordeaux CEDEX France
- INSERM U1035 University of Bordeaux Bordeaux France
| |
Collapse
|
30
|
Trémeaux P, Caporossi A, Ramière C, Santoni E, Tarbouriech N, Thélu MA, Fusillier K, Geneletti L, François O, Leroy V, Burmeister WP, André P, Morand P, Larrat S. Amplification and pyrosequencing of near-full-length hepatitis C virus for typing and monitoring antiviral resistant strains. Clin Microbiol Infect 2016; 22:460.e1-460.e10. [PMID: 26827671 DOI: 10.1016/j.cmi.2016.01.015] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2015] [Revised: 01/04/2016] [Accepted: 01/17/2016] [Indexed: 12/16/2022]
Abstract
Directly acting antiviral drugs have contributed considerable progress to hepatitis C virus (HCV) treatment, but they show variable activity depending on virus genotypes and subtypes. Therefore, accurate genotyping including recombinant form detection is still of major importance, as is the detection of resistance-associated mutations in case of therapeutic failure. To meet these goals, an approach to amplify the HCV near-complete genome with a single long-range PCR and sequence it with Roche GS Junior was developed. After optimization, the overall amplification success rate was 73% for usual genotypes (i.e. HCV 1a, 1b, 3a and 4a, 16/22) and 45% for recombinant forms RF_2k/1b (5/11). After pyrosequencing and subsequent de novo assembly, a near-full-length genomic consensus sequence was obtained for 19 of 21 samples. The genotype and subtype were confirmed by phylogenetic analysis for every sample, including the suspected recombinant forms. Resistance-associated mutations were detected in seven of 13 samples at baseline, in the NS3 (n = 3) or NS5A (n = 4) region. Of these samples, the treatment of one patient included daclatasvir, and that patient experienced a relapse. Virus sequences from pre- and posttreatment samples of four patients who experienced relapse after sofosbuvir-based therapy were compared: the selected variants seem too far from the NS5B catalytic site to be held responsible. Although tested on a limited set of samples and with technical improvements still necessary, this assay has proven to be successful for both genotyping and resistance-associated variant detection on several HCV types.
Collapse
Affiliation(s)
- P Trémeaux
- Laboratoire de Virologie, Institut de Biologie et Pathologie, Grenoble, France; UVHCI, Grenoble, France; Institut de Biologie Structurale (IBS), CEA, CNRS, University Grenoble Alpes, Grenoble, France
| | - A Caporossi
- Laboratoire de Virologie, Institut de Biologie et Pathologie, Grenoble, France; Centre d'investigation clinique, Santé publique, UJF-CNRS, Grenoble, France; Laboratoire TIMC-IMAG, UMR 5525, Université de Grenoble Alpes, Grenoble, France
| | - C Ramière
- Laboratoire de Virologie, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France
| | - E Santoni
- Laboratoire de Virologie, Institut de Biologie et Pathologie, Grenoble, France
| | - N Tarbouriech
- UVHCI, Grenoble, France; Institut de Biologie Structurale (IBS), CEA, CNRS, University Grenoble Alpes, Grenoble, France
| | - M-A Thélu
- Laboratoire de Virologie, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France
| | - K Fusillier
- Laboratoire de Virologie, Institut de Biologie et Pathologie, Grenoble, France
| | - L Geneletti
- Laboratoire de Virologie, Institut de Biologie et Pathologie, Grenoble, France
| | - O François
- Laboratoire TIMC-IMAG, UMR 5525, Université de Grenoble Alpes, Grenoble, France
| | - V Leroy
- Service d'Hépato-Gastroentérologie, CHU de Grenoble, Grenoble, France
| | - W P Burmeister
- UVHCI, Grenoble, France; Institut de Biologie Structurale (IBS), CEA, CNRS, University Grenoble Alpes, Grenoble, France
| | - P André
- Laboratoire de Virologie, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France
| | - P Morand
- Laboratoire de Virologie, Institut de Biologie et Pathologie, Grenoble, France; UVHCI, Grenoble, France; Institut de Biologie Structurale (IBS), CEA, CNRS, University Grenoble Alpes, Grenoble, France
| | - S Larrat
- Laboratoire de Virologie, Institut de Biologie et Pathologie, Grenoble, France; UVHCI, Grenoble, France; Institut de Biologie Structurale (IBS), CEA, CNRS, University Grenoble Alpes, Grenoble, France.
| |
Collapse
|
31
|
Leroy V, Milpied B, Boursault L, Taieb A, Seneschal J. Induction de tolérance à l’anakinra (Kineret®) pour une maladie de Still dans le cadre d’une réaction d’hypersensibilité retardée. Ann Dermatol Venereol 2015. [DOI: 10.1016/j.annder.2015.10.558] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
32
|
Huet N, Denis I, Martino A, Gallix B, Sturm N, Leroy V, Bricault I. Ultrasonographic assessment of liver fibrosis with computer-assisted analysis of liver surface irregularities. Diagn Interv Imaging 2015; 96:941-6. [DOI: 10.1016/j.diii.2015.02.010] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2014] [Revised: 01/06/2015] [Accepted: 02/16/2015] [Indexed: 01/10/2023]
|
33
|
Jesson J, Leroy V. Challenges of malnutrition care among HIV-infected children on antiretroviral treatment in Africa. Med Mal Infect 2015; 45:149-56. [PMID: 25861689 DOI: 10.1016/j.medmal.2015.03.002] [Citation(s) in RCA: 28] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/30/2014] [Revised: 01/04/2015] [Accepted: 03/09/2015] [Indexed: 11/24/2022]
Abstract
More than 90% of the estimated 3.2 million children with HIV worldwide, at the end of 2013, were living in sub-Saharan Africa. The management of these children was still difficult in 2014 despite the progress in access to antiretroviral drugs. A great number of HIV-infected children are not diagnosed at 6 weeks and start antiretroviral treatment late, at an advanced stage of HIV disease complicated by other comorbidities such as malnutrition. Malnutrition is a major problem in the sub-Saharan Africa global population; it is an additional burden for HIV-infected children because they do not respond as well as non-infected children to the usual nutritional care. HIV infection and malnutrition interact, creating a vicious circle. It is important to understand the relationship between these 2 conditions and the effect of antiretroviral treatment on this circle to taking them into account for an optimal management of pediatric HIV. An improved monitoring of growth during follow-up and the introduction of a nutritional support among HIV-infected children, especially at antiretroviral treatment initiation, are important factors that could improve response to antiretroviral treatment and optimize the management of pediatric HIV in resource-limited countries.
Collapse
Affiliation(s)
- J Jesson
- Inserm, centre de recherche U897, épidémiologie et biostatistiques, institut de santé publique, d'épidémiologie et de développement (ISPED), université de Bordeaux - CS61292, 146, rue Léo-Saignat, 33076 Bordeaux cedex, France.
| | - V Leroy
- Inserm, centre de recherche U897, épidémiologie et biostatistiques, institut de santé publique, d'épidémiologie et de développement (ISPED), université de Bordeaux - CS61292, 146, rue Léo-Saignat, 33076 Bordeaux cedex, France
| |
Collapse
|
34
|
Ramière C, Tremeaux P, Caporossi A, Trabaud MA, Lebossé F, Bailly F, Thélu MA, Nana J, Leroy V, Morand P, André P, Larrat S. Recent evidence of underestimated circulation of hepatitis C virus intergenotypic recombinant strain RF2k/1b in the Rhône-Alpes region, France, January to August 2014: implications for antiviral treatment. ACTA ACUST UNITED AC 2014; 19. [PMID: 25375898 DOI: 10.2807/1560-7917.es2014.19.43.20944] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Since the beginning of 2014, hepatitis C virus (HCV) recombinant forms RF2k/1b have been detected in the Rhône-Alpes French region in 10 patients originating from the Caucasus area. Circulation of this particular HCV strain is very likely to be underestimated. It is also prone to be misgenotyped when using genotyping methods based on the 5' region of the viral genome, which may lead to suboptimal treatment.
Collapse
Affiliation(s)
- C Ramière
- Laboratoire de Virologie, Hopital de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
35
|
Dahourou L, Amani-Bossé C, Coulibaly M, Meda N, Timité-Konan M, Leroy V. Malnutrition à l’initiation du traitement antirétroviral précoce de l’enfant à Abidjan, et Ouagadougou, 2011–2013. Rev Epidemiol Sante Publique 2014. [DOI: 10.1016/j.respe.2014.06.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
36
|
Coulibaly M, Amani-Bossé C, Van de Perre P, Meda N, Blanche S, Leroy V. Efficacité virologique du traitement antirétroviral pédiatrique précoce basé sur le LPV/r en Afrique. Rev Epidemiol Sante Publique 2014. [DOI: 10.1016/j.respe.2014.06.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
37
|
Nguena Nguefack H, Gwet H, Tejiokem M, Tchendjou P, Ouwe Missi Oukem-Boyer O, Nkenfou C, Domkam I, Desmonde S, Leroy V, Alioum A. Estimation de la transmission mère–enfant du VIH au Cameroun : approche par simulation. Rev Epidemiol Sante Publique 2014. [DOI: 10.1016/j.respe.2014.05.109] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
|
38
|
Eboua T, Yonaba C, Mea-Assande V, Ouedraogo S, Amani-Bossé C, Coulibaly M, Meda N, Timité-Konan M, Yé D, Amorissani-Folquet M, Lepage P, Leroy V, Blanche S. SFP PC-83 – Inclusion dans un essai du traitement antirétroviral pédiatrique en Afrique. Arch Pediatr 2014. [DOI: 10.1016/s0929-693x(14)72232-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
39
|
Timite-Konan M, Avit-Edi D, Méa-Assandé V, Aka E, Kouadio S, Folquet-Amorissani M, Amani-Bossé C, Eliam-Kouakou J, Daingui E, Abo K, Ahoba I, Leroy V. SFCP P-096 - Accès au traitement antirétroviral avant deux ans à Abidjan. Arch Pediatr 2014. [DOI: 10.1016/s0929-693x(14)71811-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
40
|
Avit-Edi D, Folquet-Amorissani M, Amani-Bossé C, Kouraï-Lago V, Timité-Konan M, Leroy V. Dépistage pédiatrique précoce et accès à la prise en charge du VIH : les obstacles à Abidjan, Côte d’Ivoire, 2011-2012. Rev Epidemiol Sante Publique 2013. [DOI: 10.1016/j.respe.2013.07.055] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
41
|
Coulibaly M, Meda N, Yonaba C, Blanche S, Van De Perre P, Leroy V. Opportunités manquées de prise en charge précoce de l’infection par le VIH du nourrisson à Ouagadougou, Burkina Faso. Rev Epidemiol Sante Publique 2013. [DOI: 10.1016/j.respe.2013.07.130] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
|
42
|
Pierre J, Elias F, Leroy V. A technique for measuring velocity and attenuation of ultrasound in liquid foams. Ultrasonics 2013; 53:622-629. [PMID: 23168271 DOI: 10.1016/j.ultras.2012.10.011] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/29/2012] [Revised: 10/19/2012] [Accepted: 10/20/2012] [Indexed: 06/01/2023]
Abstract
We describe an experimental setup specifically designed for measuring the ultrasonic transmission through liquid foams, over a broad range of frequencies (60-600kHz). The question of determining the ultrasonic properties of the foam (density, phase velocity and attenuation) from the transmission measurements is addressed. An inversion method is proposed, tested on synthetic data, and applied to a liquid foam at different times during the coarsening. The ultrasonic velocity and attenuation are found to be very sensitive to the foam bubble sizes, suggesting that a spectroscopy technique could be developed for liquid foams.
Collapse
Affiliation(s)
- J Pierre
- Laboratoire MSC, Université Paris-Diderot, CNRS, UMR 7057, Paris, France.
| | | | | |
Collapse
|
43
|
Strybulevych A, Leroy V, Shum AL, Koksel HF, Scanlon MG, Page JH. Use of an ultrasonic reflectance technique to examine bubble size changes in dough. ACTA ACUST UNITED AC 2012. [DOI: 10.1088/1757-899x/42/1/012037] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
44
|
Jouvin-Marche E, Fugier E, Thélu MA, Van Campenhout N, Hoang X, Marlu A, Leroy V, Sturm N, Zarski JP, Marche P. P134 IL28B associated polymorphism, RS12979860, controls the activity of liver lymphocytes. Cytokine 2012. [DOI: 10.1016/j.cyto.2012.06.226] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
45
|
Hézode C, Castéra L, Roudot-Thoraval F, Bouvier-Alias M, Rosa I, Roulot D, Leroy V, Mallat A, Pawlotsky JM. Liver stiffness diminishes with antiviral response in chronic hepatitis C. Aliment Pharmacol Ther 2011; 34:656-63. [PMID: 21752038 DOI: 10.1111/j.1365-2036.2011.04765.x] [Citation(s) in RCA: 96] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
Abstract
BACKGROUND Transient elastography measures liver stiffness, which correlates with the hepatic fibrosis stage and has excellent accuracy for the diagnosis of cirrhosis in patients with chronic hepatitis C. AIM To assess prospectively the kinetics of liver stiffness in treated patients with chronic hepatitis C and compare them with the viral kinetics on treatment and with the final outcome of therapy. METHODS 91 patients with chronic hepatitis C with significant fibrosis (>7.0kPa) at baseline were included. They received therapy with pegylated interferon-α and ribavirin. The kinetics of liver stiffness were characterized during therapy and thereafter by means of Fibroscan, and compared with the virological responses at weeks 4, 12, 24, end of treatment and 12 and 24weeks after. RESULTS A significant liver stiffness decrease was observed during therapy, which continued after treatment only in patients who achieved a sustained virological response. In this group, the median intra-patient decrease relative to baseline at the end of follow-up was -3.4kPa, vs-1.8kPa in the patients who did not achieve an SVR. Similar dynamics were observed in cirrhotic and non-cirrhotic patients. In multivariate analysis, only the SVR was associated with long-term improvement of liver stiffness (odds ratio: 3.10; 95% confidence interval: 1.20-8.02, P=0.019). CONCLUSIONS In patients with advanced fibrosis at the start of therapy, liver stiffness is significantly reduced during treatment, but improvement continues off treatment only in patients who achieve a sustained virological response. Liver stiffness assessment earlier than 6months after the end of therapy does not appear to be clinically meaningful.
Collapse
Affiliation(s)
- C Hézode
- Department of Hepatology and Gastroenterology, Hôpital Henri Mondor, Université Paris-Est, Créteil, France. INSERM U955, Créteil, France
| | | | | | | | | | | | | | | | | |
Collapse
|
46
|
Ndondoki C, Brou H, Timite-Konan M, Oga M, Bosse-Amani C, Dago-Akribi H, Menan H, Ekouevi D, Leroy V. Acceptabilité familiale du dépistage du VIH pédiatrique proposé en routine dans les consultations pédiatriques chez les enfants de moins de six mois, Abidjan, Côte d’Ivoire. Projet PEDI-TEST ANRS 12165. Rev Epidemiol Sante Publique 2010. [DOI: 10.1016/j.respe.2010.06.091] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
|
47
|
Oga Ma C, Brou H, Ndondoki C, Timite-Konan M, Bosse-AmaniI C, Dago-Akribi H, Ekouevy D, Leroy V. Attitudes et pratiques des personnels soignants sur le dépistage VIH pédiatrique proposé en routine chez les enfants âgés de moins de 6 mois à Abidjan, Côte d’Ivoire. Projet PEDI-TEST ANRS 12165. Rev Epidemiol Sante Publique 2010. [DOI: 10.1016/j.respe.2010.06.158] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
|
48
|
Devaud M, Hocquet T, Leroy V. Sound propagation in a monodisperse bubble cloud: from the crystal to the glass. Eur Phys J E Soft Matter 2010; 32:13-23. [PMID: 20490600 DOI: 10.1140/epje/i2010-10588-0] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/19/2009] [Revised: 03/19/2010] [Accepted: 04/09/2010] [Indexed: 05/27/2023]
Abstract
We present a theoretical study of the propagation of a monochromatic pressure wave in an unbounded monodisperse bubbly liquid. We begin with the case of a regular bubble array--a bubble crystal--for which we derive a dispersion relation. In order to interpret the different branches of this relation, we introduce a formalism, the radiative picture, which is the adaptation to acoustics of the standard splitting of the electric field in an electrostatic and a radiative part in Coulomb gauge. In the case of an irregular or completely random array--a bubble glass--and at wavelengths large compared to the size of the bubble array spatial inhomogeneities, the difference between order and disorder is not felt by the pressure wave: a dispersion relation still holds, coinciding with that of a bubble crystal with the same bubble size and air volume fraction at the centre of its first Brillouin zone. This relation is discussed and compared to that obtained by Foldy in the framework of his multiscattering approach.
Collapse
Affiliation(s)
- M Devaud
- Laboratoire Matière et Systèmes Complexes, UMR 7057, CNRS, et Université Paris Diderot, 10 rue Alice Domon et Léonie Duquet, 75205 Paris Cedex 13, France.
| | | | | |
Collapse
|
49
|
Anaky MF, Duvignac J, Wemin L, Kouakoussui A, Karcher S, Touré S, Seyler C, Fassinou P, Dabis F, N'Dri-Yoman T, Anglaret X, Leroy V. Scaling up antiretroviral therapy for HIV-infected children in Côte d'Ivoire: determinants of survival and loss to programme. Bull World Health Organ 2009; 88:490-9. [PMID: 20616968 DOI: 10.2471/blt.09.068015] [Citation(s) in RCA: 62] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2009] [Revised: 08/19/2009] [Accepted: 11/02/2009] [Indexed: 11/27/2022] Open
Abstract
OBJECTIVE To investigate deaths and losses to follow-up in a programme designed to scale up antiretroviral therapy (ART) for HIV-infected children in Côte d'Ivoire. METHODS Between 2004 and 2007, HIV-exposed children at 19 centres were offered free HIV serum tests (polymerase chain reaction tests in those aged < 18 months) and ART. Computerized monitoring was used to determine: (i) the number of confirmed HIV infections, (ii) losses to the programme (i.e. death or loss to follow-up) before ART, (iii) mortality and loss-to-programme rates during 12 months of ART, and (iv) determinants of mortality and losses to the programme. FINDINGS The analysis included 3876 ART-naïve children. Of the 1766 with HIV-1 infections (17% aged < 18 months), 124 (7.0%) died, 52 (2.9%) left the programme, 354 (20%) were lost to follow-up before ART, 259 (15%) remained in care without ART, and 977 (55%) started ART (median age: 63 months). The overall mortality rate during ART was significantly higher in the first 3 months than in months 4-12: 32.8 and 6.9 per 100 child-years of follow-up, respectively. Loss-to-programme rates were roughly double mortality rates and followed the same trend with duration of ART. Independent predictors of 12-month mortality on ART were pre-ART weight-for-age z-score < -2, percentage of CD4+ T lymphocytes < 10, World Health Organization HIV/AIDS clinical stage 3 or 4, and blood haemoglobin < 8 g/dl. CONCLUSION The large-scale programme to scale up paediatric ART in Côte d'Ivoire was effective. However, ART was often given too late, and early mortality and losses to programme before and just after ART initiation were major problems.
Collapse
Affiliation(s)
- M-F Anaky
- Aconda-VS-CI, Abidjan, Côte d'Ivoire
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
50
|
Tonwe-Gold B, Ekouevi DK, Bosse CA, Toure S, Koné M, Becquet R, Leroy V, Toro P, Dabis F, El Sadr WM, Abrams EJ. Implementing family-focused HIV care and treatment: the first 2 years' experience of the mother-to-child transmission-plus program in Abidjan, Côte d'Ivoire. Trop Med Int Health 2009; 14:204-12. [PMID: 19236666 DOI: 10.1111/j.1365-3156.2008.02182.x] [Citation(s) in RCA: 56] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
OBJECTIVES To describe a family-focused approach to HIV care and treatment and report on the first 2 years experience of implementing the mother-to-child transmission (MTCT)-plus program in Abidjan, Côte d'Ivoire. PROGRAM The MTCT-plus initiative aims to enroll HIV-infected pregnant and postpartum women in comprehensive HIV care and treatment for themselves and their families. MAIN OUTCOMES Between August 2003 and August 2005, 605 HIV-infected pregnant or postpartum women and 582 HIV-exposed infants enrolled. Of their 568 male partners reported alive, 52% were aware of their wife's HIV status and 30% were tested for HIV; 53% of these tested partners were found to be HIV-infected and 78% enrolled into the program. Overall only 10% of the women enrolled together with their infected partner. On the other hand, the program involved half of the seronegative men who came for voluntary counselling and testing (VCT) in the care of their families. Of 1624 children <15 years reported alive by their mothers (excluding the last newborn infants of the most recent pregnancy systematically screened for HIV), only 10.8% were brought in for HIV testing, of whom 12.3% were found to be HIV-infected. LESSONS LEARNED AND CHALLENGES: The family-focused model of HIV care pays attention to the needs of families and household members. The program was successful in enrolling HIV women, their partners and infants in continuous follow-up. However engaging partners and family members of newly enrolled women into care involves numerous challenges such as disclosure of HIV status by women to their partners and family members. Further efforts are required to understand barriers for families accessing HIV services as strategies to improve partner involvement and provide access to care for other children in the households are needed in this West African urban setting.
Collapse
Affiliation(s)
- B Tonwe-Gold
- ACONDA, MTCT-Plus Program, Abidjan, Côte d'Ivoire.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|